Denali Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Denali Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$574.03 - $680.96 $57,403 - $68,096	-100 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$446.73 - $548.2 $44,673 - $54,820	100 New	100 $47,000
Q3 2020 Oct 16, 2020	SELL	$544.75 - $658.21 $54,475 - $65,821	-100 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$493.32 - $643.92 $49,332 - $64,391	100 New	100 $62,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.